Mari Boggiano serves as the Director of Market Access Strategy for Malignant Hematology at Novartis, where she leverages over 20 years of extensive experience in healthcare marketing and market access. In her current role, Mari is pivotal in optimizing market access strategies for both launch...
Mari Boggiano serves as the Director of Market Access Strategy for Malignant Hematology at Novartis, where she leverages over 20 years of extensive experience in healthcare marketing and market access. In her current role, Mari is pivotal in optimizing market access strategies for both launch and in-line brands within the malignant hematology therapeutic area. Her expertise lies in developing robust value propositions tailored for payers, healthcare providers, and health system C-Suite executives, ensuring that Novartis's innovative therapies are positioned effectively in a competitive landscape.
Mari's strategic acumen is evident in her leadership of key projects that focus on launch planning and market penetration. She excels in identifying market opportunities and crafting compelling marketing communications that resonate with diverse stakeholders. Her background in managed care, biotechnology, and clinical trials enables her to navigate complex healthcare environments and drive successful outcomes for novel therapies.
In addition to her strategic responsibilities, Mari is adept at conducting competitive analysis to inform business strategies, ensuring that Novartis remains at the forefront of the malignant hematology market. Her proficiency in leveraging social media and digital platforms enhances engagement with healthcare professionals and patients alike, further solidifying Novartis's commitment to addressing unmet medical needs. With a proven track record of success in both domestic and global markets, Mari Boggiano is a key player in advancing Novartis's mission to transform the treatment landscape for patients with malignant hematology conditions.
